Websites with detailed information regarding B-cell lymphomas include the Lymphoma Research Foundation, the American Cancer Society and Mayo Clinic. B-cell lymphomas are responsible for 85 percent of all non-Hodgkin's lymphomas in the United States, according to the Lymphoma Research Foundation.
Diffuse large B-cell lymphoma represents the most common form of non-Hodgkin's lymphoma, notes the Lymphoma Research Foundation. This type of cancer strikes 30 percent of new non-Hodgkin's lymphoma patients. This fast-growing cancer usually begins in the lymph nodes, gastrointestinal tract, testes, thyroid or skin. Prognosis and treatment options depend on where the cancer starts.
Follicular lymphoma accounts for 20 percent of new cases of non-Hodgkin's lymphoma in the United States, according to the American Cancer Society. This cancer gets its name from the circular patterns of growth within lymph nodes. Follicular lymphoma normally occurs in patients more than 60 years old, and the cancer grows slowly at first. About one-third of all follicular lymphomas turn into diffuse large B-cell lymphomas.
Chronic lymphocytic leukemia starts in the blood or bone marrow, according to the American Cancer Society. Small lymphocytic lymphoma cells are found in lymph nodes and the spleen. These two slow-growing diseases are cured with non-standard lymphoma treatments.
Lymphoma-type cancers begin in B-cells or T-cells within the human body, notes Mayo Clinic. Non-Hodgkin's lymphomas occur when the body produces too many lymphocytes. These extra white blood cells do not die as quickly as normal lymphocytes and cause lymph nodes to swell.